CrossRef 14 Di Bonaventura G, Prosseda G, Del Chierico F, Cannav

CrossRef 14. Di Bonaventura G, Prosseda G, Del Chierico F, Cannavacciuolo S, Cipriani P, Petrucca A, Superti F, Ammendolia MG, Concato C, selleck compound Fiscarelli E, Casalino M, Piccolomini R, Nicoletti N, Colonna B: Molecular characterization of virulence determinants of Stenotrophomonas maltophilia strains isolated from patients affected by cystic fibrosis. Int J Immunopathol Pharmacol 2007, 20:529–537.PubMed 15. Di Bonaventura G, Pompilio A, Zappacosta R, Petrucci F, Fiscarelli E, Rossi Adavosertib mouse C, Piccolomini R: Excessive inflammatory response of DBA/2 mice to Stenotrophomonas

maltophilia lung infection: implications in cystic fibrosis. Infect Immun 2010, 78:2466–2476.PubMedCrossRef 16. Pompilio A, Piccolomini R, Picciani C, D’Antonio D, Savini V, Di Bonaventura G: Factors associated

with adherence to and biofilm formation on polystyrene by Stenotrophomonas maltophilia : the role of cell selleck inhibitor surface hydrophobicity and motility. FEMS Microbiol Lett 2008, 287:41–47.PubMedCrossRef 17. Pompilio A, Crocetta V, Confalone P, Nicoletti M, Petrucca A, Guarnieri S, Fiscarelli E, Savini V, Piccolomini R, Di Bonaventura G: Adhesion to and biofilm formation on IB3–1 bronchial cells by Stenotrophomonas maltophilia isolates from cystic fibrosis patients. BMC Microbiol 2010, 10:102.PubMedCrossRef 18. Fouhy Y, Scanlon K, Schouest K, Spillane C, Crossman L, Avison MB, Ryan RP, Dow JM: Diffusible signal factor-dependent cell-cell signaling and virulence in the nosocomial pathogen Stenotrophomonas maltophilia . J Bacteriol 2007, 189:4964–4968.PubMedCrossRef 19. Huang TP, Somers EB, Wong AC: Differential biofilm formation and motility associated with lipopolysaccharide/exopolysaccharide-coupled biosynthetic genes in Stenotrophomonas maltophilia . J Bacteriol 2006, 188:3116–3120.PubMedCrossRef 20. McKay GA, Woods DE, MacDonald KL, Poole K: Role of phosphoglucomutase of Stenotrophomonas maltophilia in lipopolysaccharide biosynthesis, virulence, and antibiotic resistance. Infect Immun Staurosporine in vivo 2003, 71:3068–3075.PubMedCrossRef 21. Denton M, Kerr KG: Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia . Clin Microbiol Rev 1998, 11:57–80.PubMed 22. Krzewinski JW, Nguyen CD,

Foster JM, Burns JL: Use of random amplified polymorphic DNA PCR to examine epidemiology of Stenotrophomonas maltophilia and Achromobacter ( Alcaligenes ) xylosoxidans from patients with cystic fibrosis. J Clin Microbiol 2001, 39:3597–3602.PubMedCrossRef 23. Nicoletti M, Iacobino A, Prosseda G, Fiscarelli E, Zarrilli R, De Carolis E, Petrucca A, Nencioni L, Colonna B, Casalino M: Stenotrophomonas maltophilia strains from cystic fibrosis patients: genomic variability and molecular characterization of some virulence determinants. Int J Med Microbiol 2011,301(1):34–43.PubMedCrossRef 24. Valdezate S, Vindel A, Maiz L, Baquero F, Escobar H, Canton R: Persistence and variability of Stenotrophomonas maltophilia in cystic fibrosis patients, Madrid, 1991–1998.

Comments are closed.